Hernán Zamaro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hernán Zamaro has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- María Laura Galluzzo Mutti
Department of Pathology, Juan P. Garrahan Hospital, Buenos Aires 1245, Argentina
2 shared publications - María Sara Felice
Department of Oncology, Juan P. Garrahan Hospital, Buenos Aires 1245, Argentina
2 shared publications - Pedro Zubizarreta
Haematology and Oncology Department, Hospital de Pediatría Garrahan, Buenos Aires 1245, Argentina
2 shared publications - Agustín Dabezies
Haematology and Oncology Department, Hospital Pereyra Rosell
1 shared publication - Carla Luciana Pennella
Haematology and Oncology Department, Hospital de Pediatría Garrahan
1 shared publication - Carolina Pages
Haematology and Oncology Department, Hospital Pereyra Rosell
1 shared publication
Latest Publications
- Open Access
- 4 August 2026
- Published by MDPI AG in Lymphatics
- Vol. 4 (3) , 42
Hodgkin Lymphoma in a Patient with Down Syndrome: Case Report and Review of the Literature
The association between Down syndrome (DS) and Hodgkin lymphoma (HL) is rare, with only a few cases reported in the literature. Here, we report the case of a pediatric patient with DS diagnosed with HL. In addition, a literature review was conducted, identifying only seven pediatric cases. We highlight treatment-related toxicity in this group of patients. Given the high survival rates of patients with HL, current strategies focus on individualizing treatment intensity based on the initial disease characteristics and the patient’s response. This consideration becomes even more important in patients with DS. The patient described in this report achieved complete metabolic remission after chemotherapy, experienced manageable grade 3 treatment-related toxicities, and remains in complete remission after 27 months of follow-up.
- 4 August 2026
- Published by MDPI AG in Lymphatics
- Vol. 4 (3) , 42
Open AccessHodgkin Lymphoma in a Patient with Down Syndrome: Case Report and Review of the Literature
The association between Down syndrome (DS) and Hodgkin lymphoma (HL) is rare, with only a few cases reported in the literature. Here, we report the case of a pediatric patient with DS diagnosed with HL. In addition, a literature review was conducted, identifying only seven pediatric cases. We highlight treatment-related toxicity in this group of patients. Given the high survival rates of patients with HL, current strategies focus on individualizing treatment intensity based on the initial disease characteristics and the patient’s response. This consideration becomes even more important in patients with DS. The patient described in this report achieved complete metabolic remission after chemotherapy, experienced manageable grade 3 treatment-related toxicities, and remains in complete remission after 27 months of follow-up.
- 28 April 2026
- Published by Taylor & Francis in Leukemia & Lymphoma
- p. 1-8
Radiotherapy may be omitted in children and adolescents with classical Hodgkin lymphoma in complete remission after frontline risk and response-adapted chemotherapy: a multicenter clinical trial (LH-GALOP 2017)
Classical Hodgkin lymphoma (cHL) is a curable disease. While the estimated 5-year survival exceeds 95% in most pediatric patients, long-term outcomes are threatened by high rates of impending late ...
- 28 April 2026
- Published by Taylor & Francis in Leukemia & Lymphoma
- p. 1-8
Radiotherapy may be omitted in children and adolescents with classical Hodgkin lymphoma in complete remission after frontline risk and response-adapted chemotherapy: a multicenter clinical trial (LH-GALOP 2017)
Classical Hodgkin lymphoma (cHL) is a curable disease. While the estimated 5-year survival exceeds 95% in most pediatric patients, long-term outcomes are threatened by high rates of impending late ...